Advertisement

Sarcopenia is Associated With Oncological Prognosis and the Incidence of Secondary Cancer in Patients With Middle/Lower Rectal Cancer

Published:October 21, 2022DOI:https://doi.org/10.1016/j.clcc.2022.10.001

      Abstract

      Objective

      This study evaluated the clinical implications of sarcopenia for patients with rectal cancer according to cancer progression.

      Summary Background Data

      The negative impact of body composition on long-term outcome has been demonstrated for various malignancies.

      Methods

      We retrospectively reviewed 708 patients with rectal cancer who underwent curative resection at our institution between 2003 and 2020. Factors contributing to long-term outcomes and the incidence of secondary cancer (ISC) were analyzed. Psoas muscle mass index (PMI) was assessed using preoperative computed tomography. Sarcopenia was defined using the PMI cut-off values for Asian adults (6.36 cm2/m2 for males and 3.92 cm2/m2 for females).

      Results

      Sarcopenia was identified in 306 patients (43.2%). Sarcopenia was associated with advanced age, low body mass index, smoking history, and advanced T-stage. Multivariate analysis showed sarcopenia was an independent poor prognostic factor for OS (HR 1.71; P = .0102) and cancer-specific survival (HR 1.64; P = .0490). Patients with sarcopenia had significantly higher mortality due to cancer-related death in stages III and IV, whereas non-rectal cancer-related death, including secondary cancer, was markedly increased in stage 0-II sarcopenic rectal patients. Five-year cumulative ISC in patients with and without sarcopenia was 11.8% and 5.9%, respectively. Multivariate analysis revealed that sarcopenia was an independent predictive factor for ISC (HR 2.05; P = .0063).

      Conclusions

      Sarcopenia helps predict survival outcomes and cause of death according to cancer stage for patients with middle/lower rectal cancer who underwent radical surgery. Furthermore, sarcopenia increased the development of secondary cancer in those patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Colorectal Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sung H
        • Ferlay J
        • Siegel RL
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2021; 71: 209-249
        • Hiramatsu K
        • Shindoh J
        • Hanaoka Y
        • et al.
        Postoperative nutritional status is predictive of the survival outcomes in patients undergoing resection of stage III colorectal cancer.
        World J Surg. 2021; 45: 3198-3205
        • Mol L
        • Ottevanger PB
        • Koopman M
        • et al.
        The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
        Eur J Cancer. 2016; 66: 138-143
        • Slankamenac K
        • Slankamenac M
        • Schlegel A
        • et al.
        Impact of postoperative complications on readmission and long-term survival in patients following surgery for colorectal cancer.
        Int J Colorectal Dis. 2017; 32: 805-811
        • Wu HL
        • Tai YH
        • Lin SP
        • et al.
        The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4,030 patients.
        Sci Rep. 2018; 8: 13345
        • Rosenberg IH.
        Sarcopenia: origins and clinical relevance.
        J Nutr. 1997; 127: 990S-991S
        • Cruz-Jentoft AJ
        • Baeyens JP
        • Bauer JM
        • et al.
        Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people.
        Age Ageing. 2010; 39: 412-423
        • Kudou K
        • Saeki H
        • Nakashima Y
        • et al.
        Prognostic Significance of Sarcopenia in patients with Esophagogastric junction cancer or upper gastric cancer.
        Ann Surg Oncol. 2017; 24: 1804-1810
        • Miyamoto Y
        • Baba Y
        • Sakamoto Y
        • et al.
        Sarcopenia is a negative prognostic factor after curative resection of colorectal Cancer.
        Ann Surg Oncol. 2015; 22: 2663-2668
        • Voron T
        • Tselikas L
        • Pietrasz D
        • et al.
        Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma.
        Ann Surg. 2015; 261: 1173-1183
        • Sun G
        • Li Y
        • Peng Y
        • et al.
        Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis.
        Int J Colorectal Dis. 2018; 33: 1419-1427
        • Trejo-Avila M
        • Bozada-Gutiérrez K
        • Valenzuela-Salazar C
        • et al.
        Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis.
        Int J Colorectal Dis. 2021; 36: 1077-1096
        • Abe S
        • Kawai K
        • Nozawa H
        • et al.
        Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.
        Int J Clin Oncol. 2022; 27: 141-153
        • Abe S
        • Nozawa H
        • Kawai K
        • et al.
        Poor nutrition and sarcopenia are related to systemic inflammatory response in patients with rectal cancer undergoing preoperative chemoradiotherapy.
        Int J Colorectal Dis. 2022; 37: 189-200
        • Watanabe J
        • Osaki T
        • Ueyama T
        • et al.
        The combination of preoperative skeletal muscle quantity and quality is an important indicator of survival in elderly patients undergoing curative gastrectomy for Gastric Cancer.
        World J Surg. 2021; 45: 2868-2877
        • Ishihara S
        • Kawai K
        • Tanaka T
        • et al.
        Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
        Dis Colon Rectum. 2017; 60: 469-476
        • Kawai K
        • Shiratori H
        • Hata K
        • et al.
        Optimal size criteria for lateral lymph node dissection after neoadjuvant chemoradiotherapy for rectal cancer.
        Dis Colon Rectum. 2021; 64: 274-283
        • Hashiguchi Y
        • Muro K
        • Saito Y
        • et al.
        Japanese society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
        Int J Clin Oncol. 2020; 25: 1-42
        • Rectum JSfCotCa
        Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3d English Edition [Secondary Publication].
        J Anus Rectum Colon. 2019; 3: 175-195
        • Hamaguchi Y
        • Kaido T
        • Okumura S
        • et al.
        Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults.
        Nutrition. 2016; 32: 1200-1205
        • Harimoto N
        • Shirabe K
        • Yamashita YI
        • et al.
        Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.
        Br J Surg. 2013; 100: 1523-1530
        • Chung E
        • Lee HS
        • Cho ES
        • et al.
        Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer.
        Clin Nutr. 2020; 39: 820-828
        • Takeda Y
        • Akiyoshi T
        • Matsueda K
        • et al.
        Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
        PLoS One. 2018; 13e0195406
        • Meyerhardt JA
        • Niedzwiecki D
        • Hollis D
        • et al.
        Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
        J Clin Oncol. 2008; 26: 4109-4115
        • Tokunaga R
        • Nakagawa S
        • Miyamoto Y
        • et al.
        The clinical impact of preoperative body composition differs between male and female colorectal cancer patients.
        Colorectal Dis. 2020; 22: 62-70
        • You JF
        • Tang R
        • Changchien CR
        • et al.
        Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum.
        Ann Surg. 2009; 249: 783-787
        • Giani A
        • Famularo S
        • Fogliati A
        • et al.
        Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy.
        World J Surg Oncol. 2022; 20: 51
        • van Vledder MG
        • Levolger S
        • Ayez N
        • et al.
        Body composition and outcome in patients undergoing resection of colorectal liver metastases.
        Br J Surg. 2012; 99: 550-557
        • da Cunha LP
        • Silveira MN
        • Mendes MCS
        • et al.
        Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: a retrospective evaluation.
        Clin Nutr ESPEN. 2019; 32: 107-112
        • Wasif N
        • Neville M
        • Gray R
        • et al.
        Competing risk of death in elderly patients with newly diagnosed stage i breast cancer.
        J Am Coll Surg. 2019; 229: 30-36
        • Kwon M
        • Roh JL
        • Song J
        • et al.
        Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.
        Ann Oncol. 2014; 25: 1208-1214
        • Sugawara K
        • Yamashita H
        • Urabe M
        • et al.
        Poor nutritional status and sarcopenia influences survival outcomes in gastric carcinoma patients undergoing radical surgery.
        Eur J Surg Oncol. 2020; 46: 1963-1970
        • Rieker RJ
        • Hammer E
        • Eisele R
        • et al.
        The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection.
        Langenbecks Arch Surg. 2002; 387: 72-76
        • Ministry of Health LaW
        Overview of the Basic Plan to Promote Cancer Control Programs.
        Ministry of Health, Labour and Welfare, Tokyo, Japan2017
        • Donin N
        • Filson C
        • Drakaki A
        • et al.
        Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.
        Cancer. 2016; 122: 3075-3086
        • Lee DH
        • Roh JL
        • Baek S
        • et al.
        Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
        Otolaryngol Head Neck Surg. 2013; 149: 579-586
        • Park YS
        • Kim JW
        • Kim BG
        • et al.
        Sarcopenia is associated with an increased risk of advanced colorectal neoplasia.
        Int J Colorectal Dis. 2017; 32: 557-565
        • Jung YS
        • Kim NH
        • Ryu S
        • et al.
        Association between low relative muscle mass and the risk of colorectal neoplasms.
        J Clin Gastroenterol. 2017; 51: e83-e89
        • Hong JT
        • Kim TJ
        • Pyo JH
        • et al.
        Impact of sarcopenia on the risk of advanced colorectal neoplasia.
        J Gastroenterol Hepatol. 2019; 34: 162-168
        • Lee SW
        • Youm Y
        • Lee WJ
        • et al.
        Appendicular skeletal muscle mass and insulin resistance in an elderly korean population: the korean social life, health and aging project-health examination cohort.
        Diabetes Metab J. 2015; 39: 37-45
        • Lim S
        • Kim JH
        • Yoon JW
        • et al.
        Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).
        Diabetes Care. 2010; 33: 1652-1654
        • Sandhu MS
        • Dunger DB
        • Giovannucci EL.
        Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.
        J Natl Cancer Inst. 2002; 94: 972-980
        • Wu X
        • Fan Z
        • Masui H
        • et al.
        Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
        J Clin Invest. 1995; 95: 1897-1905
        • Wu Y
        • Yakar S
        • Zhao L
        • et al.
        Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
        Cancer Res. 2002; 62: 1030-1035
        • Ho GYF
        • Zheng SL
        • Cushman M
        • et al.
        Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
        J Natl Cancer Inst. 2016; 108
        • Adachi Y
        • Nojima M
        • Mori M
        • et al.
        Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.
        World J Gastroenterol. 2017; 23: 3488-3495
        • Roddam AW
        • Allen NE
        • Appleby P
        • et al.
        Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
        Ann Intern Med. 2008; 149: 461-471
        • Grantzau T
        • Overgaard J.
        Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients.
        Radiother Oncol. 2015; 114: 56-65
        • Brook I.
        Late side effects of radiation treatment for head and neck cancer.
        Radiat Oncol J. 2020; 38: 84-92
        • Bostrom PJ
        • Soloway MS.
        Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?.
        Eur Urol. 2007; 52: 973-982
        • Birgisson H
        • Påhlman L
        • Gunnarsson U
        • et al.
        Occurrence of second cancers in patients treated with radiotherapy for rectal cancer.
        J Clin Oncol. 2005; 23: 6126-6131
        • Rombouts AJM
        • Hugen N
        • Elferink MAG
        • et al.
        Incidence of second tumors after treatment with or without radiation for rectal cancer.
        Ann Oncol. 2017; 28: 535-540
        • Martling A
        • Smedby KE
        • Birgisson H
        • et al.
        Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
        Br J Surg. 2017; 104: 278-287
        • Wiltink LM
        • Nout RA
        • Fiocco M
        • et al.
        increased risk of second cancer after radiotherapy in patients treated for rectal or endometrial cancer in the randomized TME, PORTEC-1, and PORTEC-2 Trials.
        J Clin Oncol. 2015; 33: 1640-1646
        • Wang TH
        • Liu CJ
        • Chao TF
        • et al.
        Second primary malignancy risk after radiotherapy in rectal cancer survivors.
        World J Gastroenterol. 2018; 24: 4586-4595
        • Klement RJ
        • Pazienza V.
        Impact of different types of diet on gut microbiota profiles and cancer prevention and treatment.
        Medicina (Kaunas). 2019; 55: 84
        • Kim CH
        • Lee SY
        • Kim HR
        • et al.
        Pathologic stage following preoperative chemoradiotherapy underestimates the risk of developing distant metastasis in rectal cancer: a comparison to staging without preoperative chemoradiotherapy.
        J Surg Oncol. 2016; 113: 692-699
        • Du CZ
        • Chen YC
        • Cai Y
        • et al.
        Oncologic outcomes of primary and post-irradiated early stage rectal cancer: a retrospective cohort study.
        World J Gastroenterol. 2011; 17: 3229-3234
        • Taira T
        • Nozawa H
        • Kawai K
        • et al.
        Prognoses in Pathologically Confirmed T1 lower rectal cancer patients with or without preoperative therapy: an analysis using the surveillance, epidemiology, and end results database.
        Oncology. 2022; 100: 82-88